Welcome to our dedicated page for Tenet Healthcare SEC filings (Ticker: THC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tenet Healthcare Corporation filings document the regulatory record of a healthcare services company with hospital operations, an ambulatory surgery platform and Conifer revenue cycle management services. Its 8-K reports disclose operating results, financial outlook updates, Regulation FD information, material agreements involving Conifer, and debt financing matters tied to senior secured first lien notes and senior notes.
Tenet's proxy and current reports also cover board composition, shareholder voting matters, executive compensation, officer transition agreements, controller and principal accounting officer appointments, equity-award terms, common stock, senior-note securities and related governance disclosures. These filings connect THC's capital structure and management oversight to its Ambulatory, Hospital and Conifer business activities.
Tenet Healthcare Corp director Meghan Fitzgerald reported routine equity compensation activity involving company common stock. On May 22, 2026, she exercised 1,333 restricted stock units, receiving the same number of Tenet common shares. The filing notes each unit was economically equivalent to one THC share.
On the same date, she disposed of 493 common shares back to the issuer at $173.78 per share. After these transactions, she held 17,087 shares of Tenet Healthcare common stock directly, and the referenced 2025 May restricted stock units were fully settled.
Director Vineeta Agarwala of Tenet Healthcare Corp exercised previously granted equity awards and increased her direct holdings of common stock. She converted 1,333 restricted stock units, each equivalent to one share of Tenet common stock, into the same number of common shares. Following this transaction, she directly owns 4,446 shares of Tenet common stock. The filing shows an exercise of derivative securities with no reported open-market purchases or sales.
Tenet Healthcare Corp director Cecil D. Haney reported routine equity compensation activity involving restricted stock units and common shares. He exercised derivative securities labeled as 2025 May Restricted Stock Units into 1,333 shares of common stock, with the units economically equivalent to Tenet common stock. A portion of this award was settled in cash and the remainder in shares, as described in the footnote. The filing also shows a disposition of 493 common shares back to the issuer at $173.78 per share. After these transactions, Haney directly holds 14,346 shares of Tenet common stock.
Tenet Healthcare Corp director Richard J. Mark reported compensation-related share movements. On 2026-05-22, he exercised 1,333 restricted stock units into an equal number of common shares at an exercise price of $0.00 per share.
On the same date, he disposed of 493 common shares back to the issuer in a transaction coded "D" at $173.78/share. After these transactions, he directly held 35,121 shares of Tenet Healthcare common stock. A footnote explains that he settled 37% of his restricted stock units for cash and 63% for shares.
Tenet Healthcare director J. Robert Kerrey reported routine equity compensation activity involving company stock. He exercised 1,643 restricted stock units, which were each the economic equivalent of one share of Tenet common stock, receiving value partly in cash and partly in shares.
According to the footnote, Kerrey settled 37% of these units for cash and 63% for shares. On the same date, he also disposed of 607 common shares to the issuer in a transaction coded as a disposition to issuer. After these transactions, he directly held 22,442 shares of Tenet common stock, indicating that the activity represents a relatively small adjustment to his overall ownership position.
Tenet Healthcare director Roy Blunt reported routine equity-compensation transactions involving company common stock. He exercised 1,333 restricted stock units that were each the economic equivalent of one share of Tenet Healthcare common stock, receiving shares as part of the settlement.
In connection with this activity, he disposed of 493 shares back to the issuer at a price of $173.78 per share. After these transactions, Blunt directly owns 5,189 shares of Tenet Healthcare common stock. The filing reflects compensation-related settlements rather than open-market buying or selling.
TENET HEALTHCARE CORP reported initial holdings for Principal Accounting Officer John Michael Grooms on a Form 3. The filing shows unvested April 2026 time-based restricted stock units covering 2,584 shares of common stock, scheduled to vest in two equal installments on April 15, 2028 and April 15, 2029. These restricted stock units will be settled in shares of common stock when they vest.
Tenet Healthcare Corporation reported Q1 2026 net operating revenues of $5,368 million and net income of $906 million, up from $622 million a year earlier. Diluted earnings per share rose to $8.01 from $4.27 as margins improved.
Operating cash flow reached $1,641 million, supported by a $540 million contract termination payment from CommonSpirit Health under an Omnibus Agreement tied to Conifer. Ambulatory Care net operating revenues grew 10.6% to $1,320 million, while hospital admissions and adjusted admissions were roughly flat.
Tenet ended the quarter with $2,967 million in cash and long-term debt of $13,128 million, and repurchased 1.346 million shares for $318 million, leaving $1,172 million authorized for future buybacks. Management also highlights potential future pressures from U.S. healthcare policy changes, including the One Big Beautiful Bill Act.
Tenet Healthcare Corp ownership filing shows Vanguard Capital Management reports beneficial ownership of 4,582,013 shares of common stock, representing 5.26% of the class. The filing states Vanguard has sole dispositive power over 4,582,013 shares and sole voting power over 670,605 shares. The disclosure notes these holdings reflect securities managed across Vanguard affiliates and funds and that the position is reported on behalf of managed accounts and investment companies.
Tenet Healthcare reported strong first quarter 2026 results, with net income available to common shareholders of $702 million, or $8.01 per diluted share, up from $406 million, or $4.27, a year earlier. Net operating revenues rose to $5.37 billion from $5.22 billion.
Adjusted diluted EPS increased 10.6% to $4.82, while consolidated Adjusted EBITDA was essentially flat at $1.16 billion and a 21.6% margin. Results included $413 million of revenue and an approximate $40 million favorable non‑recurring pre‑tax impact from early conclusion of a Conifer contract with CommonSpirit Health.
Operating cash flow for the quarter was $1.64 billion, and adjusted free cash flow was $978 million. Tenet repurchased 1.35 million shares for $318 million and ended March 31, 2026 with a net debt to Adjusted EBITDA ratio of 2.24x. Full‑year 2026 guidance calls for net operating revenues of $21.5–$22.3 billion and Adjusted EBITDA of $4.49–$4.79 billion.